Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:440:111-145.
doi: 10.1007/82_2020_202.

Messenger RNA-Based Vaccines Against Infectious Diseases

Mohamad-Gabriel Alameh  1 , Drew Weissman  2 , Norbert Pardi  1
Affiliations
Review

Messenger RNA-Based Vaccines Against Infectious Diseases

Mohamad-Gabriel Alameh et al. Curr Top Microbiol Immunol. 2022.

Abstract

In vitro-transcribed, messenger RNA-based infectious disease vaccines have the potential to successfully address many of the weaknesses of traditional vaccine platforms, such as the lack of potency and/or durability of vaccine protection, time-consuming, and expensive manufacturing, and, in some cases, safety issues. This optimism is fueled by a great deal of impressive recent data demonstrating that mRNA vaccines have many of the attributes that are necessary for a viable new vaccine class for human use. This review briefly describes mRNA vaccine types, discusses the most relevant and recent publications on infectious disease mRNA vaccines, and highlights the hurdles that need to be overcome to bring this promising novel vaccine modality to the clinic.

Keywords: Clinical trials; Infectious diseases; LNP; SAM; Vaccines; mRNA.

PubMed Disclaimer

References

    1. Abrams MT et al (2010) Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. Mol Ther 18:171–180. https://doi.org/10.1038/mt.2009.208 - DOI - PubMed
    1. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7:657–663. https://doi.org/10.1002/jgm.696 - DOI - PubMed
    1. Alberer M et al (2017) Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet 390(10101):1511–1520. https://doi.org/10.1016/S0140-6736(17)31665-3 - DOI - PubMed
    1. Allard SD et al (2012) A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. Clin Immunol 142:252–268. https://doi.org/10.1016/j.clim.2011.10.010 - DOI - PubMed
    1. An Y et al (2013) Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms. J Proteome Res 12:3707–3720. https://doi.org/10.1021/pr400329k - DOI - PubMed - PMC

LinkOut - more resources